G6PD and Plasmodium vivax malaria: To develop shorter primaquine dosing regimens with acceptable safety profiles for G6PD-deficient patients with vivax malaria, we compared ascending primaquine dose regimens with a single high dose of primaquine (45 mg) in hemizygote G6PD-deficient male volunteers in Thailand (11).